This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during 2025. Click here to view PDF
Menu
This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during 2025. Click here to view PDF
PathCare is pleased to announce that, from 12 January 2026, we will provide plasma metanephrine (MN), normetanephrine (NMN), and 3-methoxytyramine (3MT) measured using High-Resolution Accurate-Mass (LC-HRAM). This upgrade aligns our service with international best practice for the biochemical evaluation of catecholamine-secreting tumours. Click here to view PDF